Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Document And Entity Information

v3.23.1
Document And Entity Information
 12 Months Ended
Dec. 31, 2022
shares
Document Information Line Items  
Entity Registrant Name CollPlant Biotechnologies Ltd.
Trading Symbol CLGN
Document Type 20-F
Current Fiscal Year End Date --12-31
Entity Common Stock, Shares Outstanding 11,186,481
Amendment Flag false
Entity Central Index Key 0001631487
Entity Current Reporting Status Yes
Entity Voluntary Filers No
Entity Filer Category Accelerated Filer
Entity Well-known Seasoned Issuer No
Document Period End Date Dec. 31, 2022
Document Fiscal Year Focus 2022
Document Fiscal Period Focus FY
Entity Emerging Growth Company true
Entity Shell Company false
Entity Ex Transition Period false
ICFR Auditor Attestation Flag false
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Entity File Number 001-38370
Entity Incorporation, State or Country Code L3
Entity Address, Address Line One 4 Oppenheimer
Entity Address, Address Line Two Weizmann Science Park
Entity Address, City or Town Rehovot
Entity Address, Postal Zip Code 7670104
Entity Address, Country IL
Title of 12(b) Security Ordinary shares, par value NIS 1.50 per share
Security Exchange Name NASDAQ
Entity Interactive Data Current Yes
Document Accounting Standard U.S. GAAP
Auditor Firm ID 1281
Auditor Name KOST FORER GABBAY & KASIERER
Auditor Location Tel-Aviv, Israel
Business Contact  
Document Information Line Items  
Entity Address, Address Line One 4 Oppenheimer
Entity Address, Address Line Two Weizmann Science Park
Entity Address, City or Town Rehovot
Entity Address, Postal Zip Code 7670104
Entity Address, Country IL
Contact Personnel Name Yehiel Tal
City Area Code +972
Local Phone Number 73 232 5600